Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation

被引:40
作者
Puppin, Cinzia [1 ]
Durante, Cosimo [2 ]
Sponziello, Marialuisa [2 ]
Verrienti, Antonella [2 ]
Pecce, Valeria [2 ]
Lavarone, Elisa [1 ]
Baldan, Federica [1 ]
Campese, Antonio Francesco [3 ]
Boichard, Amelie [4 ]
Lacroix, Ludovic [4 ]
Russo, Diego [5 ]
Filetti, Sebastiano [2 ]
Damante, Giuseppe [1 ,6 ]
机构
[1] Univ Udine, Dipartimento Sci Med & Biol, I-33100 Udine, Italy
[2] Univ Roma La Sapienza, Dipartimento Med Interna & Specialita Med, I-00185 Rome, Italy
[3] Univ Roma La Sapienza, Dipartimento Med Mol, I-00185 Rome, Italy
[4] Univ Paris 11, Inst Gustave Roussy, Villejuif, France
[5] Univ Catanzaro, Dipartimento Sci Salute, Catanzaro, Italy
[6] Azienda Osped Univ S Maria della Misericordia, Udine, Italy
关键词
miRNA; DICER; DGCR8; XPO5; Medullary thyroid carcinoma; MICRORNA BIOGENESIS; CELL-PROLIFERATION; POOR-PROGNOSIS; RAS MUTATIONS; MEN; 2A; CANCER; DICER; EXPRESSION; PROTOONCOGENE; DROSHA;
D O I
10.1007/s12020-014-0204-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Abnormal expression of non-coding micro RNA (miRNA) has been described in medullary thyroid carcinoma (MTC). Expression of genes encoding factors involved in miRNA biogenesis results often deregulated in human cancer and correlates with aggressive clinical behavior. In this study, expression of four genes involved in miRNA biogenesis (DICER, DROSHA, DCGR8, and XPO5) was investigated in 54 specimens of MTC. Among them, 33 and 13 harbored RET and RAS mutations, respectively. DICER, DGCR8, and XPO5 mRNA levels were significantly overexpressed in MTC harboring RET mutations, in particular, in the presence of RET634 mutation. When MTCs with RET and RAS mutations were compared, only DGCR8 displayed a significant difference, while MTCs with RAS mutations did not show significant differences with respect to non-mutated tumors. We then attempted to correlate expression of miRNA biogenesis genes with tumor aggressiveness. According to the TNM status, MTCs were divided in two groups and compared (N0 M0 vs. N1 and/or M1): for all four genes no significant difference was detected. Cell line experiments, in which expression of a RET mutation is silenced by siRNA, suggest the existence of a causal relationship between RET mutation and overexpression of DICER, DGCR8, and XPO5 genes. These findings demonstrate that RET-but not RAS-driven tumorigenic alterations include abnormalities in the expression of some important genes involved in miRNA biogenesis that could represent new potential markers for targeted therapies in the treatment of RET-mutated MTCs aimed to restore the normal miRNA expression profile.
引用
收藏
页码:528 / 536
页数:9
相关论文
共 42 条
  • [31] Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification
    Mian, Caterina
    Pennelli, Gianmaria
    Barollo, Susi
    Cavedon, Elisabetta
    Nacamulli, Davide
    Vianello, Federica
    Negro, Isabella
    Pozza, Giulia
    Boschin, Isabella Merante
    Pelizzo, Maria Rosa
    Rugge, Massimo
    Mantero, Franco
    Girelli, Maria Elisa
    Opocher, Giuseppe
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 164 (06) : 971 - 976
  • [32] SPECIFIC MUTATIONS OF THE RET PROTOONCOGENE ARE RELATED TO DISEASE PHENOTYPE IN MEN 2A AND FMTC
    MULLIGAN, LM
    ENG, C
    HEALEY, CS
    CLAYTON, D
    KWOK, JBJ
    GARDNER, E
    PONDER, MA
    FRILLING, A
    JACKSON, CE
    LEHNERT, H
    NEUMANN, HPH
    THIBODEAU, SN
    PONDER, BAJ
    [J]. NATURE GENETICS, 1994, 6 (01) : 70 - 74
  • [33] MicroRNA expression profiling of thyroid tumors: Biological significance and diagnostic utility
    Nikiforova, Marina N.
    Tseng, George C.
    Steward, David
    Diorio, Donna
    Nikiforov, Yuri E.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (05) : 1600 - 1608
  • [34] Deregulation of microRNA expression in follicular cell-derived human thyroid carcinomas
    Pallante, Pierlorenzo
    Visone, Rosa
    Croce, Carlo Maria
    Fusco, Alfredo
    [J]. ENDOCRINE-RELATED CANCER, 2010, 17 (01) : F91 - F104
  • [35] Minireview: RET: Normal and abnormal functions
    Santoro, M
    Melillo, RM
    Carlomagno, F
    Vecchio, G
    Fusco, A
    [J]. ENDOCRINOLOGY, 2004, 145 (12) : 5448 - 5451
  • [36] Epigenetics-related genes in prostate cancer: Expression profile in prostate cancer tissues, androgen-sensitive and -insensitive cell lines
    Shaikhibrahim, Zaki
    Lindstrot, Andreas
    Ochsenfahrt, Jacqueline
    Fuchs, Kerstin
    Wernert, Nicolas
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 31 (01) : 21 - 25
  • [37] Current management of medullary thyroid cancer
    Sippel, Rebecca S.
    Kunnimalaiyaan, Muthusamy
    Chen, Herbert
    [J]. ONCOLOGIST, 2008, 13 (05) : 539 - 547
  • [38] Molecular Differences Between Human Thyroid Follicular Adenoma and Carcinoma Revealed by Analysis of a Murine Model of Thyroid Cancer
    Sponziello, Marialuisa
    Lavarone, Elisa
    Pegolo, Enrico
    Di Loreto, Carla
    Puppin, Cinzia
    Russo, Marika A.
    Bruno, Rocco
    Filetti, Sebastiano
    Durante, Cosimo
    Russo, Diego
    Di Cristofano, Antonio
    Damante, Giuseppe
    [J]. ENDOCRINOLOGY, 2013, 154 (09) : 3043 - 3053
  • [39] Extensive post-transcriptional regulation of microRNAs and its implications for cancer
    Thomson, J. Michael
    Newman, Martin
    Parker, Joel S.
    Morin-Kensicki, Elizabeth M.
    Wright, Tricia
    Hammond, Scott M.
    [J]. GENES & DEVELOPMENT, 2006, 20 (16) : 2202 - 2207
  • [40] Control of translation and mRNA degradation by miRNAs and siRNAs
    Valencia-Sanchez, MA
    Liu, JD
    Hannon, GJ
    Parker, R
    [J]. GENES & DEVELOPMENT, 2006, 20 (05) : 515 - 524